---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-057831"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:49:56.815417+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Iterum CMO Sailaja Puttagunta resigns effective May 31; Steven Aronin to lead clinical development

## Summary
- CMO Sailaja Puttagunta resigns for personal reasons, effective May 31, 2024; no disagreement with company.
- Dr. Puttagunta will remain as consultant during regulatory review of oral sulopenem NDA for uncomplicated UTI.
- Steven Aronin, SVP and Head of Clinical Development, will assume leadership of development and regulatory activities.
- Transition occurs during FDA review of resubmitted NDA for oral sulopenem; potential impact on timeline.

## SEC filing metadata
- accession: 0000950170-24-057831
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024057831/0000950170-24-057831-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024057831/itrm-20240510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-057831
- JSON: https://secwatch.observer/filing/0000950170-24-057831.json
- Plain text: https://secwatch.observer/filing/0000950170-24-057831.txt

## Key facts
- Executive change
  Sailaja Puttagunta resigned as Chief Medical Officer at Iterum Therapeutics plc.
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On May 8, 2024, Sailaja Puttagunta M.D. notified Iterum Therapeutics plc (the “Company”) of her decision to resign as Chief Medical Officer the Company, effective May 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017024057831/0000950170-24-057831-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.